Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) that leads to the death of neurons and oligodendrocytes, which cannot be measured in living subjects. Physiological cellular death, otherwise known as apoptosis, progresses through a series of stages which culmina...
Main Authors: | Ruturaj Masvekar, Jordan Mizrahi, John Park, Peter R. Williamson, Bibiana Bielekova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.01241/full |
Similar Items
-
Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
by: Ruturaj Masvekar, et al.
Published: (2021-03-01) -
Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
by: Paavali A. Hannikainen, et al.
Published: (2020-11-01) -
Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01) -
Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
by: Krista D. DiSano, et al.
Published: (2021-02-01) -
Pro-apoptotic kinases levels in cerebrospinal fluid as potential future biomarkers in Alzheimer’s Disease
by: Claire ePAQUET, et al.
Published: (2015-08-01)